{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825893885419136.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.jtcvs.2017.03.153"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022522317308991?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022522317308991?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"28625774"}}],"dc:title":[{"@value":"Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma"}],"description":[{"notation":[{"@value":"The aim of this study was to identify clinical factors associated with lepidic growth in resected clinical stage IA radiologic pure-solid lung adenocarcinoma for identifying a possible sublobar resection candidate in the population.Clinicopathologic data were reviewed for 200 surgically resected clinical stage IA pure-solid lung adenocarcinomas. Radiologic pure-solid tumor was defined as a tumor without a ground-glass opacity component, that is, a consolidation tumor ratio equal to 1.0. Lepidic predominant adenocarcinoma included adenocarcinomas in situ, minimally invasive adenocarcinomas, and lepidic predominant invasive adenocarcinomas.A total of 57 patients (29%) had lepidic predominant adenocarcinoma. The 5-year overall survival of clinical stage IA pure-solid adenocarcinoma was 83.4% and that of lepidic predominant adenocarcinoma and nonlepidic predominant adenocarcinoma was 98.1% versus 76.6% (P = .0012). A multivariate analysis revealed that maximum standardized uptake value was an independently significant variable of lepidic predominant adenocarcinoma (P  .0001) and a significant prognostic factor (P = .034). The predictive criterion of lepidic predominant adenocarcinoma was maximum standardized uptake value 3.3 or less based on a receiver operating characteristic curve, and 77 patients (39%) who met this criterion showed less pathologic invasiveness regarding lymphatic (P = .0012) and vascular (P  .0001) invasions, nodal metastasis (P = .0007), and better overall survival than those who did not (maximum standardized uptake value ≤3.3 vs 3.3 rates being 91.7% vs 78.6%, P = .0031). Moreover, the 3-year locoregional recurrence-free survival of the sublobar resection arm was significantly worse than that of the lobectomy arm when the tumor showed maximum standardized uptake value greater than 3.3 (62.7% vs 82.9%, P = .0281).Higher maximum standardized uptake value may be useful for identifying patients with clinical stage IA radiologic pure-solid lung adenocarcinoma in whom sublobar resection should not be considered, even if technically feasible."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825893885419138","@type":"Researcher","foaf:name":[{"@value":"Aritoshi Hattori"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893885419137","@type":"Researcher","foaf:name":[{"@value":"Takeshi Matsunaga"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893885419136","@type":"Researcher","foaf:name":[{"@value":"Kazuya Takamochi"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893885419140","@type":"Researcher","foaf:name":[{"@value":"Shiaki Oh"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893885419139","@type":"Researcher","foaf:name":[{"@value":"Kenji Suzuki"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00225223"}],"prism:publicationName":[{"@value":"The Journal of Thoracic and Cardiovascular Surgery"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2017-09","prism:volume":"154","prism:number":"3","prism:startingPage":"1100","prism:endingPage":"1108"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","http://www.elsevier.com/open-access/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0022522317308991?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0022522317308991?httpAccept=text/plain"}],"createdAt":"2017-05-18","modifiedAt":"2019-08-31","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Aged,%2080%20and%20over","dc:title":"Aged, 80 and over"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Lung%20Neoplasms","dc:title":"Lung Neoplasms"},{"@id":"https://cir.nii.ac.jp/all?q=Adenocarcinoma","dc:title":"Adenocarcinoma"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Prognosis","dc:title":"Prognosis"},{"@id":"https://cir.nii.ac.jp/all?q=Fluorodeoxyglucose%20F18","dc:title":"Fluorodeoxyglucose F18"},{"@id":"https://cir.nii.ac.jp/all?q=Lymphatic%20Metastasis","dc:title":"Lymphatic Metastasis"},{"@id":"https://cir.nii.ac.jp/all?q=Positron-Emission%20Tomography","dc:title":"Positron-Emission Tomography"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Neoplasm%20Invasiveness","dc:title":"Neoplasm Invasiveness"},{"@id":"https://cir.nii.ac.jp/all?q=Neoplasm%20Recurrence,%20Local","dc:title":"Neoplasm Recurrence, Local"},{"@id":"https://cir.nii.ac.jp/all?q=Radiopharmaceuticals","dc:title":"Radiopharmaceuticals"},{"@id":"https://cir.nii.ac.jp/all?q=Pneumonectomy","dc:title":"Pneumonectomy"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Retrospective%20Studies","dc:title":"Retrospective Studies"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004232331558144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168810524416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Artificial intelligence analysis of three-dimensional imaging data derives factors associated with postoperative recurrence in patients with radiologically solid-predominant small-sized lung cancers"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593764271104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Maximum standardized uptake value of the primary tumor does not improve candidate selection for sublobar resection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593810706432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Radiomics is feasible for prediction of spread through air spaces in patients with nonsmall cell lung cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816790373632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prognostic role of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography with an image-based harmonization technique: A multicenter retrospective study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390854717438473344","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Latest Clinical Evidence and Operative Strategy for Small-Sized Lung          Cancers"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.jtcvs.2017.03.153"},{"@type":"OPENAIRE","@value":"doi_dedup___::faa0dae976b1b0a9426a944a1a36da89"},{"@type":"CROSSREF","@value":"10.1093/ejcts/ezab541_references_DOI_SicNz3Zv6DaqYyLtkDTTBoceCVm"},{"@type":"CROSSREF","@value":"10.14789/jmj.jmj21-0030-ot_references_DOI_SicNz3Zv6DaqYyLtkDTTBoceCVm"},{"@type":"CROSSREF","@value":"10.1016/j.jtcvs.2021.06.053_references_DOI_SicNz3Zv6DaqYyLtkDTTBoceCVm"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-93002-4_references_DOI_SicNz3Zv6DaqYyLtkDTTBoceCVm"},{"@type":"CROSSREF","@value":"10.1016/j.xjon.2023.02.004_references_DOI_SicNz3Zv6DaqYyLtkDTTBoceCVm"},{"@type":"CROSSREF","@value":"10.1016/j.jtcvs.2018.05.053_references_DOI_SicNz3Zv6DaqYyLtkDTTBoceCVm"}]}